Literature DB >> 34464544

Retinopathy and Systemic Disease Morbidity in Severe COVID-19.

Jessica G Shantha1, Sara C Auld2,3, Casey Anthony1, Laura Ward4, Max W Adelman4, Cheryl L Maier5, Kenneth W Price1, Jesse T Jacob3,4, Tolulope Fashina1, Casey Randleman1, Lucy T Xu1, Joshua Barnett1, Ofer Sadan6, Prem A Kandiah6, Jay B Varkey4, Colleen S Kraft4,5, Nadine Rouphael4, Susanne Linderman7, Rafi Ahmed7, Carolyn Drews-Botsch8, Jesse J Waggoner4, Max Weinmann2, David J Murphy2, Steven Yeh1,9.   

Abstract

PURPOSE: To assess the prevalence of retinopathy and its association with systemic morbidity and laboratory indices of coagulation and inflammatory dysfunction in severe COVID-19.
DESIGN: Retrospective, observational cohort study.
METHODS: Adult patients hospitalized with severe COVID-19 who underwent ophthalmic examination from April to July 2020 were reviewed. Retinopathy was defined as one of the following: 1) Retinal hemorrhage; 2) Cotton wool spots; 3) Retinal vascular occlusion. We analyzed medical comorbidities, sequential organ failure assessment (SOFA) scores, clinical outcomes, and laboratory values for their association with retinopathy.
RESULTS: Thirty-seven patients with severe COVID-19 were reviewed, the majority of whom were female (n = 23, 62%), Black (n = 26, 69%), and admitted to the intensive care unit (n = 35, 95%). Fourteen patients had retinopathy (38%) with retinal hemorrhage in 7 (19%), cotton wool spots in 8 (22%), and a branch retinal artery occlusion in 1 (3%) patient. Patients with retinopathy had higher SOFA scores than those without retinopathy (8.0 vs. 5.3, p = .03), higher rates of respiratory failure requiring invasive mechanical ventilation and shock requiring vasopressors (p < .01). Peak D-dimer levels were 28,971 ng/mL in patients with retinopathy compared to 12,575 ng/mL in those without retinopathy (p = .03). Peak CRP was higher in patients with cotton wool spots versus those without cotton wool spots (354 mg/dL vs. 268 mg/dL, p = .03). Multivariate logistic regression modeling showed an increased risk of retinopathy with higher peak D-dimers (aOR 1.32, 95% CI 1.01-1.73, p = .04) and male sex (aOR 9.6, 95% CI 1.2-75.5, p = .04).
CONCLUSION: Retinopathy in severe COVID-19 was associated with greater systemic disease morbidity involving multiple organs. Given its association with coagulopathy and inflammation, retinopathy may offer insight into disease pathogenesis in patients with severe COVID-19.

Entities:  

Keywords:  COVID-19; ophthalmic disease; retinopathy

Mesh:

Year:  2021        PMID: 34464544      PMCID: PMC8562588          DOI: 10.1080/09273948.2021.1952278

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.728


  29 in total

Review 1.  Purtscher's retinopathy.

Authors:  S A Buckley; B James
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

2.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

3.  Retinal findings in patients with COVID-19: Results from the SERPICO-19 study.

Authors:  Alessandro Invernizzi; Alessandro Torre; Salvatore Parrulli; Federico Zicarelli; Marco Schiuma; Valeria Colombo; Andrea Giacomelli; Mario Cigada; Laura Milazzo; Annalisa Ridolfo; Ivano Faggion; Laura Cordier; Marta Oldani; Sara Marini; Paolo Villa; Giuliano Rizzardini; Massimo Galli; Spinello Antinori; Giovanni Staurenghi; Luca Meroni
Journal:  EClinicalMedicine       Date:  2020-09-20

4.  Hypertensive retinopathy. Description, classification, and prognosis.

Authors:  J B Walsh
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

5.  Retinal findings in patients with COVID-19.

Authors:  Paula M Marinho; Allexya A A Marcos; André C Romano; Heloisa Nascimento; Rubens Belfort
Journal:  Lancet       Date:  2020-05-12       Impact factor: 79.321

6.  Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.

Authors:  Siamak Khavandi; Elsa Tabibzadeh; Mohammad Naderan; Saeed Shoar
Journal:  Cont Lens Anterior Eye       Date:  2020-04-27       Impact factor: 3.077

7.  Central retinal vein occlusion in a young healthy COVID-19 patient: A case report.

Authors:  Tal Yahalomi; Joseph Pikkel; Roee Arnon; Yuval Pessach
Journal:  Am J Ophthalmol Case Rep       Date:  2020-11-16

8.  Hemi-retinal vein occlusion in a young patient with COVID-19.

Authors:  Avni P Finn; Rahul N Khurana; Louis K Chang
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-05

Review 9.  Ocular Complications in the Prone Position in the Critical Care Setting: The COVID-19 Pandemic.

Authors:  Priyanka Sanghi; Mohsan Malik; Ibtesham T Hossain; Bita Manzouri
Journal:  J Intensive Care Med       Date:  2020-09-28       Impact factor: 3.510

10.  Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19).

Authors:  Marvi Cheema; Helya Aghazadeh; Samir Nazarali; Andrew Ting; Jennifer Hodges; Alexandra McFarlane; Jamil N Kanji; Nathan Zelyas; Karim F Damji; Carlos Solarte
Journal:  Can J Ophthalmol       Date:  2020-04-02       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.